文献速递细胞病理与分子病理神经与头颈病理

米兰系统SUMP类别中细胞形态学亚型与恶性肿瘤风险的双机构研究

Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study.
PubMed 文献 · Cancer Cytopathol · 2019-05-22

该双机构研究分析了65例细针穿刺诊断为SUMP且有手术随访的病例,评估不同细胞形态学亚型(基底样、嗜酸细胞样、未指定)的肿瘤风险(RON)和恶性肿瘤风险(ROM)。总体RON为95.4%,ROM为33.8%;基底样、嗜酸细胞样和未指定亚型的ROM分别为38.5%、7.7%和41%,显示ROM因亚型而异,但总体ROM与米兰系统目标率相近。

要点

  • SUMP总体RON为95.4%,ROM为33.8%。
  • 基底样亚型ROM为38.5%,嗜酸细胞样为7.7%,未指定为41%。
  • 多形性腺瘤是最常见良性肿瘤(23.1%),黏液表皮样癌是最常见恶性肿瘤(9.2%)。

核心结论

  • SUMP的ROM因细胞形态学亚型不同而差异显著,但总体ROM与米兰系统目标率大致相同。
  • 不同细胞形态学亚型的RON均保持高位。

研究设计与样本

  • 回顾性双机构研究,检索Johns Hopkins医院和西北大学2013至2018年细针穿刺诊断为SUMP且有手术随访的病例。
  • 共纳入65例患者,男31例、女34例,年龄15至87岁(平均55.2岁)。

主要发现

  • 65例中基底样特征13例(20%),嗜酸细胞样特征13例(20%),未指定特征39例(60%),未见透明细胞特征病例。
  • 总体RON为95.4%(62/65),ROM为33.8%(22/65)。
  • 基底样、嗜酸细胞样和未指定亚型的RON分别为92.3%、100%和94.9%,ROM分别为38.5%、7.7%和41%。
  • 最常见良性肿瘤为多形性腺瘤(23.1%),最常见恶性肿瘤为黏液表皮样癌(9.2%)。

临床怎么用

  • 对SUMP病例应结合细胞形态学亚型评估恶性肿瘤风险。
  • 充分采样、免疫组化染色及熟悉化生和反应性改变可能改善诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Salivary gland neoplasm of uncertain malignant potential (SUMP) is a diagnostic category in the Milan System for Reporting Salivary Gland Cytopathology. The objective of this study was to assess the risk of neoplasm (RON) and the risk of malignancy (ROM) in SUMP cases by evaluating them based on their prominent cytomorphology. METHODS: The pathology databases were searched for cases of fine-needle aspiration-diagnosed SUMP at The Johns Hopkins Hospital and Northwestern University from 2013 to 2018. Only cytopathology cases diagnosed as SUMP that had available surgical follow-up were included. RESULTS: Sixty-five patients with SUMP were identified, including 31 men and 34 women who ranged in age from 15 to 87 years (mean age, 55.2 years). Sixty-five cases had histologic follow-up, including 13 (20%) with basaloid features, 13 (20%) with oncocytic features, and 39 (60%) with unspecified features. No cases with clear cell features were found. Overall, the RON in the SUMP category was 95.4% (62 of 65 cases), and the ROM was 33.8% (22 of 65 cases). The RON in SUMPs with basaloid, oncocytic, and unspecified subtypes was 92.3%, 100%, and 94.9%, respectively, whereas the ROM was 38.5%, 7.7%, and 41%, respectively. The most common benign neoplasm was pleomorphic adenoma (23.1%), whereas mucoepidermoid carcinoma (9.2%) was the most common malignant neoplasm. CONCLUSIONS: This study shows that the ROM differs significantly based on cytomorphology subtypes, whereas the overall ROM is approximately the same as the target rate in the Milan System for Reporting Salivary Gland Cytopathology. Moreover, the RON remains high in the SUMP category among different cytomorphology subtypes. Adequate sampling, immunohistochemical staining, and familiarity with metaplastic and reactive changes may improve the diagnosis.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Chowsilpa S, An D, Lose H, et al. Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study. Cancer Cytopathol. 2019. PMID: 31116514. doi:10.1002/cncy.22150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。